A subtype‐selective photoswitchable agonist for precise manipulation of GABA A receptors
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70066 ↗At a glance
Journal article in British Journal of Pharmacology, 2025. Written by Simon Miguel M Lopez and 2 co-authors. Institution: Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan. Major MEDLINE topics: Receptors, GABA-A, GABA-A Receptor Agonists, Azo Compounds. Cited 1 times so far (Crossref); 50 references. Funded by: Academia Sinica, Taiwan, Institute of Biomedical Sciences, Academia Sinica, Taiwan, National Science and Technology Council, Taiwan.
Abstract (original language)
Background and Purpose Neuronal inhibition is largely mediated by type‐A GABA receptors (GABA A Rs), a family of ligand‐gated chloride‐permeable channels, which can be sub‐classified by their subunit composition. Unravelling the function and distribution of each GABA A R subtype is essential for a holistic understanding of GABAergic inhibition in health and diseases. Photopharmacology, a technique that utilises light‐sensitive compounds to precisely manipulate endogenous proteins, is powerful for this purpose. To resolve the molecular complexity of neuronal inhibition, we aimed to develop subtype‐selective photoswitchable agonists for GABA A Rs. Experimental Approach Inspired by THIP (gaboxadol), an agonist selective for δ subunit‐containing GABA A Rs (δ‐GABA A Rs), we merged a photoswitch moiety ( az obenzene) with an analogue of THIP ( i so gu vacine) to construct Az‐IGU . Using whole‐cell voltage‐clamp recording, Az‐IGU was tested on 13 GABA A R subtypes expressed in human embryonic kidney (HEK) cells. Optical activation of endogenous GABA A Rs was examined via electrophysiology in cultured cortical neurons. Key Results In HEK cells, Az‐IGU exerted reversible photo‐agonism selectively for α4β3δ and α6β3δ GABA A Rs, two major mediators of tonic inhibition. Pharmacological and mutagenesis studies suggested that activation of the α4β3δ GABA A R involves interaction between Az‐IGU and the GABA‐binding pocket and is strongly correlated with the spontaneous activity of the receptor. In cultured cortical neurons, photoisomerisation of Az‐IGU triggered responses that enabled reversible control of action potential firing. Conclusions and Implications GABA A Rs are potential therapeutic targets for many disorders. However, their physiological and pathophysiological roles remain largely unexplored. Az‐IGU may enable photopharmacological studies of α4/6β3δ GABA A Rs, providing new opportunities for biomedical and neurobiological applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan.
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
- Neuroscience Program of Academia Sinica (NPAS), Academia Sinica, Taipei, Taiwan.
ORCID profiles: Simon Miguel M Lopez, Wan-Chen Lin
Funding
- Academia Sinica, Taiwan
- Institute of Biomedical Sciences, Academia Sinica, Taiwan
- National Science and Technology Council, Taiwan
Cite
APA
Lopez, S. M. M., Lee, J. R., & Lin, W. C. (2025). A subtype‐selective photoswitchable agonist for precise manipulation of GABA A receptors. British Journal of Pharmacology. https://doi.org/10.1111/bph.70066
Vancouver
Lopez SMM, Lee JR, Lin WC. A subtype‐selective photoswitchable agonist for precise manipulation of GABA A receptors. British Journal of Pharmacology. 2025. doi:10.1111/bph.70066
BibTeX
@article{Lopez2025,
author = {Lopez, Simon Miguel M and Lee, Jay-Ron and Lin, Wan-Chen},
title = {A subtype‐selective photoswitchable agonist for precise manipulation of GABA A receptors},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70066}
}
EUVIMED